on 16 Jan 2020
Last Applicant/ Owned by
Tessa Therapeutics Ltd
8 TEMASEK BOULEVARD, #24-02 SUNTEC TOWER THREE Singapore 038988
, ,
Serial Number
UK00801521234 filed on 16th Jan 2020
Registration Number
UK00801521234 registered on
10th Aug 2020
Correspondent Information
Frances M. Jagla and all other attorneys of Christensen O'Connor Johnson Kindness
Christensen O'Connor Johnson Kindness, 1201 Third Avenue, Suite 3600 Seattle WA 98101
,
Chemical and biochemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells; kits comprising chemical reagents and biochemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; kits comprising chemical reagents and biochemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells; chemical, biochemical and biotechnological products for industrial and scientific purposes; chemical, biochemical and biotechnological products for use in research and test laboratories; reagents for the preparation or transport of biological molecules.
Pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer and autoimmune diseases for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of cancer and autoimmune disease; pharmaceutical preparations for T-cell therapy; biological preparations for the treatment of cancer and autoimmune disease; medical preparations for therapeutic purposes; preparations for cell therapy; preparations for cancer therapies; chimeric antigen receptors (CAR) and therapeutic preparations thereof; antibodies; preparations for genetically modifying human cells for medical purposes, including viral vectors; preparations of blood extracted from humans which have been adapted for therapeutic purposes; biopharmaceutical agents in the form of oncolytic viruses for the prevention, diagnosis, and treatment of cancer and autoimmune disease.
UK00801521234
Word
Individual